Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 28;12(4):661-664.
doi: 10.21037/tlcr-23-64. Epub 2023 Apr 4.

New potential targeted strategies in small cell lung cancer

María de Toro  1 , Cristina Pangua  1 , Gloria Serrano-Montero  1 , Miguel Ángel Lara  1   2 , Jacobo Rogado  1
Affiliations
Editorial

New potential targeted strategies in small cell lung cancer

María de Toro et al. Transl Lung Cancer Res. .
No abstract available

Keywords: Targeted therapy; small cell lung cancer (SCLC); ubiquitin proteasome system (UPS).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-64/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Ganti AKP, Loo BW, Bassetti M, et al. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021;19:1441-64. 10.6004/jnccn.2021.0058 - DOI - PMC - PubMed
    1. Dingemans AC, Früh M, Ardizzoni A, et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:839-53. 10.1016/j.annonc.2021.03.207 - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. 10.3322/caac.21708 - DOI - PubMed
    1. Horn L, Mansfield AS, Szczęsna A, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med 2018;379:2220-9. 10.1056/NEJMoa1809064 - DOI - PubMed
    1. Paz-Ares L, Dvorkin M, Chen Y, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 2019;394:1929-39. 10.1016/S0140-6736(19)32222-6 - DOI - PubMed